19 May 2013
Keywords: fabre-kramer/gsk, submit, amended, nda, gepirone, er, houston
Article | 14 May 2007
Houston, Texas, USA-based Fabre-Kramer Pharmaceuticals and UK drug major GlaxoSmithKline have submitted an amendment to the New Drug
Application to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 May 2007
17 May 2013
© 2013 thepharmaletter.com